Epidemiology

You have full text access to this OnlineOpen article

Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

  1. Nina Føns Johnsen1,†,*,
  2. Anne Tjønneland1,
  3. Birthe L.R. Thomsen1,
  4. Jane Christensen1,
  5. Steffen Loft2,
  6. Christine Friedenreich3,
  7. Timothy J. Key4,
  8. Naomi E. Allen4,
  9. Petra H. Lahmann5,6,
  10. Lotte Mejlvig7,
  11. Kim Overvad8,
  12. Rudolf Kaaks9,
  13. Sabine Rohrmann9,
  14. Heiner Boing5,
  15. Gesthimani Misirli10,
  16. Antonia Trichopoulou10,
  17. Dimosthenis Zylis10,
  18. Rosario Tumino11,
  19. Valeria Pala12,
  20. H. Bas Bueno-de-Mesquita13,
  21. Lambertus A. Kiemeney14,
  22. Laudina Rodríguez Suárez15,
  23. Carlos A. Gonzalez16,
  24. Maria-José Sánchez17,
  25. José María Huerta18,
  26. Aurelio Barricarte Gurrea19,
  27. Jonas Manjer20,
  28. Elisabet Wirfält21,
  29. Kay-Tee Khaw22,
  30. Nick Wareham23,
  31. Paolo Boffetta24,
  32. Lars Egevad24,
  33. Sabina Rinaldi24,
  34. Elio Riboli25

Article first published online: 3 FEB 2009

DOI: 10.1002/ijc.24326

Issue

International Journal of Cancer

International Journal of Cancer

Volume 125, Issue 4, pages 902–908, 15 August 2009

Additional Information

How to Cite

Johnsen, N. F., Tjønneland, A., Thomsen, B. L.R., Christensen, J., Loft, S., Friedenreich, C., Key, T. J., Allen, N. E., Lahmann, P. H., Mejlvig, L., Overvad, K., Kaaks, R., Rohrmann, S., Boing, H., Misirli, G., Trichopoulou, A., Zylis, D., Tumino, R., Pala, V., Bueno-de-Mesquita, H. B., Kiemeney, L. A., Suárez, L. R., Gonzalez, C. A., Sánchez, M.-J., Huerta, J. M., Gurrea, A. B., Manjer, J., Wirfält, E., Khaw, K.-T., Wareham, N., Boffetta, P., Egevad, L., Rinaldi, S. and Riboli, E. (2009), Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int. J. Cancer, 125: 902–908. doi: 10.1002/ijc.24326

Author Information

  1. 1

    Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark

  2. 2

    Institute of Public Health, University of Copenhagen, Copenhagen, Denmark

  3. 3

    Division of Population Health, Alberta Cancer Board, Calgary, Alberta, Canada

  4. 4

    Cancer Epidemiology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  5. 5

    Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany

  6. 6

    The University of Queensland, School of Population Health, Herston Queensland 4006, Australia

  7. 7

    Department of Occupational Therapy and Physiotherapy, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

  8. 8

    Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

  9. 9

    Division of Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany

  10. 10

    Department of Hygiene and Epidemiology, University of Athens Medical School, Athens, Greece

  11. 11

    Cancer Registry, Azienda Ospedaliera “Civile M.P. Arezzo,” Ragusa, Italy

  12. 12

    Nutritional Epidemiology Unit, National Cancer Institute, Milan, Italy

  13. 13

    National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

  14. 14

    Departments of Epidemiology and Urology, Radboud University Nijmegen Medical Centre, The Netherlands

  15. 15

    Public Health Directorate, Asturias, Spain

  16. 16

    Department of Epidemiology, Catalan Institute of Oncology, Barcelona, Spain

  17. 17

    Andalusian School of Public Health, Granada, and CIBER Epidemiología y Salud Pública (CIBERESP), Spain

  18. 18

    CIBER de Epidemiología y Salud Pública and Servicio de Epidemiología, Consejería de Sanidad, Murcia, Spain

  19. 19

    Public Health Institute of Navarra, Pamplona, and CIBER Epidemiología y Salud Pública (CIBERESP), Spain

  20. 20

    Department of Surgery, Malmö University Hospital, Malmö, Sweden

  21. 21

    Department of Clinical Sciences, Lund University, Malmö, Sweden

  22. 22

    Department of Public Health Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom

  23. 23

    MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge, United Kingdom

  24. 24

    International Agency for Research on Cancer, Lyon, France

  25. 25

    Department of Epidemiology and Public Health, Imperial College, London, United Kingdom

  1. †

    Fax: +45-35-25-7731.

*Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark

Publication History

  1. Issue published online: 11 JUN 2009
  2. Article first published online: 3 FEB 2009
  3. Manuscript Accepted: 18 DEC 2008
  4. Manuscript Received: 29 SEP 2008

Funded by

  • Europe Against Cancer Programe of the European Commission (SANCO)
  • Danish Cancer Society
  • Danish Medical Research Counsil
  • Danish Graduate School in Public Health
  • German Cancer Aid
  • Ligue Nationale contre le Cancer
  • 3M Company
  • INSERM
  • German Cancer Research Center
  • German Federal Ministry of Education and Research
  • Dutch Ministry of Public Health
  • Welfare and Sports
  • National Cancer Registry and the Regional Cancer Registries Amsterdam
  • East and Maastricht of The Netherlands
  • Norwegian Cancer Society
  • Norwegian Research Council
  • Health Research Fund (FIS) of the Spanish Ministry of Health
  • Greek Ministry of Health and Social Solidarity
  • Hellenic Health Foundation
  • Italian Association for Research on Cancer
  • Compagnia di San Paolo, Italy
  • Spanish Regional Governments of Andalucia, Asturias
  • Basque Country
  • Murcia and Navarra
  • ISCIII Red de Centros RCESP C03/09, Spain
  • Swedish Cancer Society
  • Swedish Scientific Council
  • Regional Government of Skåne, Sweden
  • Cancer Research UK
  • Medical Research Council, UK
  • Stroke Association, UK
  • British Heart Foundation
  • Department of Health, UK
  • Food Standards Agency, UK
  • Wellcome Trust, UK
  • University of Sydney and the Cancer Institute, NSW, Australia
  • Alberta Heritage Foundation for Medical Research (Health Research Award)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (126K)

References

  • 1
    EbleJN,SauterG,EpsteinJ,SesterhennI, eds. Pathology and genetics of tumors of the urinary system and male genital organs. Lyon: IARC Press, 2004.
  • 2
    Torti DC,Matheson GO. Exercise and prostate cancer. Sports Med 2004; 34: 363–9.
  • 3
    World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR, 2007.
  • 4
    Oliveria SA,Kohl HW,III,Trichopoulos D,Blair SN. The association between cardiorespiratory fitness and prostate cancer. Med Sci Sports Exerc 1996; 28: 97–104.
  • 5
    Krishnadasan A,Kennedy N,Zhao Y,Morgenstern H,Ritz B. Nested case-control study of occupational physical activity and prostate cancer among workers using a job exposure matrix. Cancer Causes Control 2008; 19: 107–14.
  • 6
    Norman A,Moradi T,Gridley G,Dosemeci M,Rydh B,Nyren O,Wolk A. Occupational physical activity and risk for prostate cancer in a nationwide cohort study in Sweden. Br J Cancer 2002; 86: 70–5.
  • 7
    Clarke G,Whittemore AS. Prostate cancer risk in relation to anthropometry and physical activity: the national health and nutrition examination survey I epidemiological follow-up study. Cancer Epidemiol Biomarkers Prev 2000; 9: 875–81.
  • 8
    Giovannucci EL,Liu Y,Leitzmann MF,Stampfer MJ,Willett WC. A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 2005; 165: 1005–10.
  • 9
    Littman AJ,Kristal AR,White E. Recreational physical activity and prostate cancer risk (United States). Cancer Causes Control 2006; 17: 831–41.
  • 10
    Patel AV,Rodriguez C,Jacobs EJ,Solomon L,Thun MJ,Calle EE. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol Biomarkers Prev 2005; 14: 275–9.
  • 11
    Wannamethee SG,Shaper AG,Walker M. Physical activity and risk of cancer in middle-aged men. Br J Cancer 2001; 85: 1311–6.
  • 12
    Hartman TJ,Albanes D,Rautalahti M,Tangrea JA,Virtamo J,Stolzenberg R,Taylor PR. Physical activity and prostate cancer in the alpha-tocopherol, beta-carotene (ATBC) cancer prevention study (Finland). Cancer Causes Control 1998; 9: 11–18.
  • 13
    Polednak AP. College athletics, body size, and cancer mortality. Cancer 1976; 38: 382–7.
    Direct Link:
  • 14
    Cerhan JR,Torner JC,Lynch CF,Rubenstein LM,Lemke JH,Cohen MB,Lubaroff DM,Wallace RB. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 1997; 8: 229–38.
  • 15
    Clemmensen IH. Physical activity and cancer. Ph.D. thesis. University of Copenhagen, Copenhagen, 1998.
  • 16
    Hsing AW,McLaughlin JK,Zheng W,Gao YT,Blot WJ. Occupation, physical activity, and risk of prostate cancer in Shanghai, People's Republic of China. Cancer Causes Control 1994; 5: 136–40.
  • 17
    Lee IM,Sesso HD,Paffenbarger RS,Jr. A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control 2001; 12: 187–93.
  • 18
    Liu S,Lee IM,Linson P,Ajani U,Buring JE,Hennekens CH. A prospective study of physical activity and risk of prostate cancer in US physicians. Int J Epidemiol 2000; 29: 29–35.
  • 19
    Lund Nilsen TI,Johnsen R,Vatten LJ. Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer 2000; 82: 1358–63.
  • 20
    Paffenbarger RS,Jr,Hyde RT,Wing AL. Physical activity and incidence of cancer in diverse populations: a preliminary report. Am J Clin Nutr 1987; 45(1 Suppl ): 312–7.
  • 21
    Putnam SD,Cerhan JR,Parker AS,Bianchi GD,Wallace RB,Cantor KP,Lynch CF. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 2000; 10: 361–9.
  • 22
    Severson RK,Nomura AM,Grove JS,Stemmermann GN. A prospective analysis of physical activity and cancer. Am J Epidemiol 1989; 130: 522–9.
  • 23
    Steenland K,Nowlin S,Palu S. Cancer incidence in the national health and nutrition survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995; 4: 807–11.
  • 24
    Thune I,Lund E. Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 1994; 5: 549–56.
  • 25
    Zeegers MP,Dirx MJ,van den Brandt PA. Physical activity and the risk of prostate cancer in the Netherlands cohort study, results after 9.3 years of follow-up. Cancer Epidemiol Biomarkers Prev 2005; 14: 1490–5.
  • 26
    Klassen AC,Platz EA. What can geography tell us about prostate cancer? Am J Prev Med 2006; 30(2 Suppl ): S7–15.
  • 27
    Riboli E,Kaaks R. The EPIC Project: rationale and study design. European prospective investigation into cancer and nutrition. Int J Epidemiol 1997; 26 ( Suppl 1): S6–14.
  • 28
    Riboli E,Hunt KJ,Slimani N,Ferrari P,Norat T,Fahey M,Charrondiere UR,Hemon B,Casagrande C,Vignat J,Overvad K,Tjonneland A, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113–24.
  • 29
    Haftenberger M,Schuit AJ,Tormo MJ,Boeing H,Wareham N,Bueno-de-Mesquita HB,Kumle M,Hjartaker A,Chirlaque MD,Ardanaz E,Andren C,Lindahl B, et al. Physical activity of subjects aged 50-64 years involved in the European prospective investigation into cancer and nutrition (EPIC). Public Health Nutr 2002; 5: 1163–76.
  • 30
    Wareham NJ,Jakes RW,Rennie KL,Schuit J,Mitchell J,Hennings S,Day NE. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European prospective investigation into cancer and nutrition (EPIC) study. Public Health Nutr 2003; 6: 407–13.
  • 31
    Pols MA,Peeters PH,Ocke MC,Slimani N,Bueno-de-Mesquita HB,Collette HJ. Estimation of reproducibility and relative validity of the questions included in the EPIC physical activity questionnaire. Int J Epidemiol 1997; 26( Suppl 1): S181–9.
  • 32
    Breslow NE,Day NE. Rates and rate standardization. Statistical methods in cancer research, 2nd ed. Lyon: IARC, 1987. 48–80.
  • 33
    Korn EL,Graubard BI,Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997; 145: 72–80.
  • 34
    Greenland S. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology 1995; 6: 450–4.
  • 35
    Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995; 6: 356–65.
  • 36
    Nilsen TI,Romundstad PR,Vatten LJ. Recreational physical activity and risk of prostate cancer: a prospective population-based study in Norway (the HUNT study). Int J Cancer 2006; 119: 2943–7.
    Direct Link:
  • 37
    Ainsworth BE,Haskell WL,Whitt MC,Irwin ML,Swartz AM,Strath SJ,O'Brien WL,Bassett DR,Jr,Schmitz KH,Emplaincourt PO,Jacobs DR,Jr,Leon AS. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32(9 Suppl ): S498–504.
  • 38
    Lunn M,McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524–32.
  • 39
    Hennekens CH,Buring JE. Epidemiology in medicine. Philadelphia: Lippincott Williams & Wilkins, 1987.
  • 40
    Slattery ML. Physical activity and colorectal cancer. Sports Med 2004; 34: 239–52.
  • 41
    Friedenreich C,Norat T,Steindorf K,Boutron-Ruault MC,Pischon T,Mazuir M,Clavel-Chapelon F,Linseisen J,Boeing H,Bergman M,Johnsen NF,Tjonneland A, et al. Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006; 15: 2398–407.
  • 42
    Lahmann PH,Friedenreich C,Schuit AJ,Salvini S,Allen NE,Key TJ,Khaw KT,Bingham S,Peeters PH,Monninkhof E,Bueno-de-Mesquita HB,Wirfalt E, et al. Physical activity and breast cancer risk: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2007; 16: 36–42.
  • 43
    Steindorf K,Friedenreich C,Linseisen J,Rohrmann S,Rundle A,Veglia F,Vineis P,Johnsen NF,Tjonneland A,Overvad K,Raaschou-Nielsen O,Clavel-Chapelon F, et al. Physical activity and lung cancer risk in the European prospective investigation into cancer and nutrition cohort. Int J Cancer 2006; 119: 2389–97.
    Direct Link:
  • 44
    Melia J,Moss S,Johns L. Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int 2004; 94: 51–6.
    Direct Link:
  • 45
    Otto SJ,van dC,I,Liem MK,Korfage IJ,Lous JJ,Schroder FH,de Koning HJ. Effective PSA contamination in the Rotterdam section of the European randomized study of screening for prostate cancer. Int J Cancer 2003; 105: 394–9.
    Direct Link:
  • 46
    Paez A,Lujan M,Llanes L,Romero I,de la Cal MA,Miravalles E,Berenguer A. PSA-use in a Spanish industrial area. Eur Urol 2002; 41: 162–6.
  • 47
    D'Ambrosio G,Samani F,Cancian M,De MC. Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database. Eur J Cancer Prev 2004; 13: 383–6.
  • 48
    Sirovich BE,Schwartz LM,Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003; 289: 1414–20.
View Full Article (HTML) Get PDF (126K)